Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 8, 2011, Pages 2025-2033

  Vallotton, Laure ^a   Hadaya, Karine ^b,c   Venetz, Jean Pierre ^a,c   Buehler, Leo H ^b,c   Ciuffreda, Donatella ^a,c   Nseir, Ghaleb ^a,c   Codarri, Laura ^a   Villard, Jean ^b,c   Pantaleo, Giuseppe ^a   Pascual, Manuel ^a,c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INTERLEUKIN 7 RECEPTOR ALPHA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3; BIOLOGICAL MARKER; IL2RA PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR, ALPHA CHAIN; INTERLEUKIN-7 RECEPTOR, ALPHA CHAIN;

ACTIVATED EFFECTOR T LYMPHOCYTE; ADULT; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL POPULATION; CHRONIC GRAFT REJECTION; CHRONIC HUMORAL REJECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ADOLESCENT; AGED; BLOOD; CELLULAR IMMUNITY; CHILD; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL MONITORING; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METHODOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SWITZERLAND; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MONITORING, IMMUNOLOGIC; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-7; RETROSPECTIVE STUDIES; SWITZERLAND; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80051556040     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09611010     Document Type: Article

References (33)

1. Shevach EM: From vanilla to 28 flavors: Multiple varieties of T regulatory cells. Immunity 25: 195-201, 2006
2. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164, 1995
3. Kang SM, Tang Q, Bluestone JA: CD4+ CD25+ regulatory T cells in transplantation: Progress, challenges and prospects. Am J Transplant 7: 1457-1463, 2007
4. Salama AD, Najafian N, Clarkson MR, Harmon WE, Sayegh MH: Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 14: 1643-1651, 2003
5. Velthuis JH, Mol WM, Weimar W, Baan CC: CD4+ CD25bright+ regulatory T cells can mediate donor non-reactivity in long-term immunosuppressed kidney allograft patients. Am J Transplant 6: 2955-2964, 2006
6. Baan CC, Velthuis JH, van Gurp EA, Mol WM, Klepper M, Ijzermans JN, Weimar W: Functional CD25(bright+) alloresponsive T cells in fully immunosuppressed renal allograft recipients. Clin Transplant 21: 63-71, 2007
7. Szanya V, Ermann J, Taylor C, Holness C, Fathman CG: The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol 169: 2461-2465, 2002
8. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, Mak TW, Sakaguchi S: Immunologic self-tolerance maintained by CD25(+) CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192: 303-310, 2000
9. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S: Stimulation of CD25(+) CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3: 135-142, 2002
10. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol 4: 330-336, 2003
11. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061, 2003
12. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, Solomon M, Selby W, Alexander SI, Nanan R, Kelleher A, de St Groth BF: Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203: 1693-1700, 2006
13. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, de St Groth BF, Clayberger C, Soper DM, Ziegler SF, Bluestone JA: CD 127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J Exp Med 203: 1701-1711, 2006
14. Codarri L, Vallotton L, Ciuffreda D, Venetz JP, Garcia M, Hadaya K, Buhler L, Rotman S, Pascual M, Pantaleo G: Expansion and tissue infiltration of an allospecific CD4+ CD25+ CD45RO+ IL-7Rαhigh cell population in solid organ transplant recipients. J Exp Med 204: 1533-1541, 2007
15. Ciuffreda D, Codarri L, Buhler L, Vallotton L, Giostra E, Mentha G, Morel P, Pantaleo G, Pascual M: Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4(+)CD25(+)CD45RO(+)IL-7ralpha(high) T cells. Liver Transpl 16: 49-55, 2010
16. Dijke IE, Korevaar SS, Caliskan K, Balk AHMM, Maat APWM, Weimar W, Baan CC: Inadequate immune regulatory function of CD4+ CD25bright+ FoxP3+ T cells in heart transplant patients who experience acute cellular rejection. Transplantation 87: 1191-1200, 2009
17. Aubert V, Venetz JP, Pantaleo G, Pascual M: Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Hum Immunol 70: 580-583, 2009
18. Gibney EM, Cagle LR, Freed B, Warnell SE, Chan L, Wiseman AC: Detection of donor-specific antibodies using HLA-coated microspheres: Another tool for kidney transplant risk stratification. Nephrol Dial Transplant 21: 2625-2629, 2006
19. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V: Banff '07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8: 753-760, 2008
20. Hoffmann HJ, Malling TM, Topcu A, Ryder LP, Nielsen KR, Varming K, Dahl R, Omland O, Sigsgaard T: CD4dimCD25bright Treg cell frequencies above a standardized gating threshold are similar in asthmatics and controls. Cytometry A 71: 371-388, 2007
21. Segundo DS, Ruiz JC, Izquierdo M, Fernández-Fresnedo G, Gómez-Alamillo C, Merino R, Benito MJ, Cacho E, Rodrigo E, Palomar R, López-Hoyos M, Arias M: Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+ CD25+ FOXP3+ regulatory T cells in renal transplant recipients. Transplantation 82: 550-557, 2006
22. Ruggenenti P, Perico N, Gotti E, Cravedi P, D'Agati V, Gagliardini E, Abbate M, Gaspari F, Cattaneo D, Noris M, Casiraghi F, Todeschini M, Cugini D, Conti S, Remuzzi G: Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant pa-tients given alemtuzumab induction from chronic allograft injury. Transplantation 84: 956-964, 2007
23. Noris M, Casiraghi F, Todeschini M, Cravedi P, Cugini D, Monteferrante G, Aiello S, Cassis L, Gotti E, Gaspari F, Cattaneo D, Perico N, Remuzzi G: Regulatory T cells and T cell depletion: Role of immunosuppressive drugs. J Am Soc Nephrol 18: 1007-1018, 2007
24. Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, Roncarolo MG: Rapamycin promotes expansion of functional CD4+ CD25+ FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 177: 8338-8347, 2006
25. Strauss L, Whiteside TL, Knights A, Bergmann C, Knuth A, Zippelius A: Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. J Immunol 178: 320-329, 2007
26. Keever-Taylor CA, Browning MB, Johnson BD, Truitt RL, Bredeson CN, Behn B, Tsao A: Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo expanded CD25 enriched products from healthy donors and patients with multiple sclerosis. Cytotherapy 9: 144-157, 2007
27. Louis S, Braudeau C, Giral M, Dupont A, Moizant F, Robillard N, Moreau A, Soulillou JP, Brouard S: Contrasting CD25hi CD4+ T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 81: 398-407, 2006
28. Coenen JJ, Koenen HJ, van Rijssen E, Hilbrands LB, Joosten I: Rapamycin, and not cyclosporine A, preserves the highly suppressive CD27+ subset of human CD4+ CD25+ regulatory T cells. Blood 107: 1018-1023, 2006
29. Gao W, Lu Y, El Essawy B, Oukka M, Kuchroo VK, Strom TB: Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen specific regulatory T cells. Am J Transplant 7: 1722-1732, 2007
30. Hendrikx TK, Velthuis JH, Klepper M, van Gurp E, Geel A, Schoordijk W, Baan CC, Weimar W: Monotherapy rapamycin allows an increase of CD4 CD25 FoxP3 T cells in renal recipients. Transpl Int 22: 884-891, 2009
31. Bluestone JA, Liu W, Yabu JM, Laszik ZG, Putnam A, Belingheri M, Gross DM, Townsend RM, Vincenti F: The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am J Transplant 8: 2086-2096, 2008
32. Sewgobind VD, Kho MM, van der Laan LJ, Hendrikx TK, van Dam T, Tilanus HW, IJzermans JN, Weimar W, Baan CC: The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients. Nephrol Dial Transplant 24: 1635-1644, 2009
33. Gurkan S, Luan Y, Dhillon N, Allam SR, Montague T, Bromberg JS, Ames S, Lerner S, Ebcioglu Z, Nair V, Dinavahi R, Sehgal V, Heeger P, Schroppel B, Murphy B: Immune reconstitution after rabbit antithymocyte globulin. Am J Transplant 10: 2132-2141, 2010